[HTML][HTML] Role of p53 in breast cancer progression: An insight into p53 targeted therapy

C Marvalim, A Datta, SC Lee - Theranostics, 2023 - ncbi.nlm.nih.gov
The transcription factor p53 is an important regulator of a multitude of cellular processes. In
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …

[HTML][HTML] The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy

E Pavitra, J Kancharla, VK Gupta, K Prasad… - Biomedicine & …, 2023 - Elsevier
Breast cancer (BC) is the second most fatal disease and is the prime cause of cancer allied
female deaths. BC is caused by aberrant tumor suppressor genes and oncogenes regulated …

Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery

F Davodabadi, SF Sajjadi, M Sarhadi… - European Journal of …, 2023 - Elsevier
Conventional chemotherapy, one of the most widely used cancer treatment methods, has
serious side effects, and usually results in cancer treatment failure. Drug resistance is one of …

Heavy metals: toxicity and human health effects

K Jomova, SY Alomar, E Nepovimova, K Kuca… - Archives of …, 2024 - Springer
Heavy metals are naturally occurring components of the Earth's crust and persistent
environmental pollutants. Human exposure to heavy metals occurs via various pathways …

Telomere function and regulation from mouse models to human ageing and disease

C Jones-Weinert, L Mainz, J Karlseder - Nature Reviews Molecular Cell …, 2024 - nature.com
Telomeres protect the ends of chromosomes but shorten following cell division in the
absence of telomerase activity. When telomeres become critically short or damaged, a DNA …

Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer

V Canu, S Vaccarella, A Sacconi, C Pulito… - Cell Death & …, 2024 - nature.com
Triple negative breast cancer (TNBC) is an aggressive disease which currently has no
effective therapeutic targets and prominent biomarkers. The Sperm Associated antigen 5 …

Mechanistic insights into the dual role of CCAR2/DBC1 in cancer

HJ Kim, SJ Moon, JH Kim - Experimental & Molecular Medicine, 2023 - nature.com
Cell cycle and apoptosis regulator 2 (CCAR2), also known as deleted in breast cancer 1
(DBC1), has been recently identified as a master regulator of transcriptional processes and …

Mitochondrial signaling pathways and their role in cancer drug resistance

A Sharma, T Virmani, G Kumar, A Sharma, R Virmani… - Cellular …, 2024 - Elsevier
Mitochondria, traditionally known as cellular powerhouses, now emerge as critical signaling
centers influencing cancer progression and drug resistance. The review highlights the role …

[HTML][HTML] Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy …

Q Ge, Z Zhao, X Li, F Yang, M Zhang… - Clinical and …, 2024 - ncbi.nlm.nih.gov
Dear Editor, Prostate cancer (PCa) is traditionally considered an immunologically cold
tumour characterized by an immunosuppressive tumour microenvironment (TME) and a …

Harnessing Artificial Intelligence for the detection and management of Colorectal Cancer Treatment

M Jacob, RP Reddy, RI Garcia, AP Reddy… - Cancer Prevention …, 2024 - aacrjournals.org
Currently, eight million people in the United States suffer from cancer and it is a major global
health concern. Early detection and interventions are urgently needed for all cancers …